Could a malaria drug help understand prostate cancer?

NCT ID NCT06408298

Recruiting now Knowledge-focused Sponsor: Lionel.D.Lewis, MD Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is for men with localized prostate cancer who are scheduled for surgery to remove the prostate. Participants will take hydroxychloroquine (a drug used for malaria) or a placebo daily before surgery. The goal is to see how the drug affects certain cell processes in the tumor and to check its safety. This is a small, early-phase trial focused on learning, not on treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESECTABLE LOCALIZED PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RESECTABLE LOCALIZED PROSTATE CANCER

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Dartmouth-Hitchcock Medical Center
RECRUITING

Lebanon, New Hampshire, 03756, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Contact Email: •••••@•••••